An International Pulmonary Embolism Registry Using EKOS

Completed

Conditions studied: Pulmonary Embolism and Thrombosis

In brief

This registry is designed to understand acoustic pulse thrombolysis (APT) treatment regimens used as standard of care globally for pulmonary embolism. The registry will include individuals who have already received the APT treatment and those that will undergo APT treatment.

Key facts

Study ID
NCT03426124
Run by
Boston Scientific Corporation
People needed
1480
Starts
2018-03-01
Expected to finish
2020-09-30
Last updated by the study team
2023-02-22

Who can join

Age: 18 and older, up to 80. Sex: any. Healthy volunteers: not accepted.

Where it is running

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.